Allspring Global Investments Holdings, LLC
Position in APGE — Apogee Therapeutics, Inc.
CIK 1890906
CHARLOTTE, NC
Position in APGE
as of Mar 31, 2026
· filed May 5, 2026
Position Value
$509,396
+$99,163 QoQ
Shares Held
6,052
+11.4% QoQ
Ownership
0.008%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2024
5 quarters on record
Voting authority
Sole 36%
Shared 0%
None 64%
Common Shares in APGE Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Allspring Global Investments Holdings, LLC holds $767,651,533 across 75 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARGX |
Argenx SE
|
170,829 | $158,490,019 | |
| 2 | EXEL |
Exelixis, Inc.
|
1,998,471 | $108,736,806 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
140,631 | $69,855,635 | |
| 4 | BBIO |
BridgeBio Pharma, Inc.
|
742,547 | $55,304,900 | |
| 5 | ASND |
Ascendis Pharma A/S
|
178,738 | $47,672,997 | |
| 6 | CORT |
Corcept Therapeutics Inc
|
523,192 | $45,491,543 | |
| 7 | REGN |
Regeneron Pharmaceuticals, Inc.
|
69,700 | $43,460,737 | |
| 8 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
67,668 | $36,334,331 |
All Filings in APGE
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $509,396 | 6,052 | Shares | Defined | 2026-05-05 | |
| 2025-12-31 | $410,233 | 5,435 | Shares | Defined | 2026-01-15 | |
| 2025-06-30 | $214,152 | 4,931 | Shares | Defined | 2025-07-25 | |
| 2024-09-30 | $198,423 | 3,378 | Shares | Defined | 2024-10-18 | |
| 2024-06-30 | $142,801 | 3,629 | Shares | Defined | 2024-07-26 | |
| No filing history on record for this holder in this stock. | ||||||